Skip Nav Destination
Issues
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2024, Vol. 102, No. 12
Clinical Study
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients
Subject Area:
Oncology
Mert Erciyestepe; Oğuzhan Selvi; Gülhan Dinç; Ahmet Emin Öztürk; Okan Aydın; Şermin Dinç Sonuşen; Tuğçe Kübra Güneş; Tugay Avcı; Sezai Vatansever; Emir Çelik; Muhammed Mustafa Atcı
Oncology (2024) 102 (12): 1009–1017.
https://doi.org/10.1159/000540334
Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes
Subject Area:
Oncology
Mohammad A.J. Abdulla; Mahmood B. Aldapt; Prem Chandra; Susanna El Akiki; Awni Alshurafa; Abdulqadir J. Nashwan; Liam J. Fernyhough; Sundus Sardar; Ammar Chapra; Mohamed A. Yassin
Oncology (2024) 102 (12): 1018–1028.
https://doi.org/10.1159/000539982
Oncology and Informatics – Research Article
Artificial Intelligence-Driven Prediction Revealed CFTR Associated with Therapy Outcome of Breast Cancer: A Feasibility Study
Subject Area:
Oncology
Oncology (2024) 102 (12): 1029–1040.
https://doi.org/10.1159/000540395
Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer
Subject Area:
Oncology
Jingkai Zhou; Haihang Nie; Xiaoqiang Yang; Fan Wang; Panpan Yu; Yali Yu; Yumei Ning; Jun Lai; Haizhou Wang; Qiu Zhao; Fei Xu
Oncology (2024) 102 (12): 1041–1055.
https://doi.org/10.1159/000540441
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study
Subject Area:
Oncology
Ivana Ristevski; Kaitlyn Flegg; Mawj Al-Hammadi; Morgan Livingstone; Taline Dorna; Leslie Low; Jill Robert; Alissa Ulster; Stephanie Kletke; Ashwin Mallipatna; Katherine Paton; Helen Dimaras; on behalf of the Canadian Retinoblastoma Research Advisory Board
Oncology (2024) 102 (12): 1056–1071.
https://doi.org/10.1159/000540055
Changes in Mutations of Cell-Free DNA and Liver Tumor Tissue in Patients with Advanced Hepatocellular Carcinoma before and after Introduction of Lenvatinib
Subject Area:
Oncology
Mio Tsuruoka; Masashi Ninomiya; Jun Inoue; Tomoaki Iwata; Akitoshi Sano; Kosuke Sato; Masazumi Onuki; Satoko Sawahashi; Atsushi Masamune
Oncology (2024) 102 (12): 1072–1083.
https://doi.org/10.1159/000540438
Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib
Subject Area:
Oncology
Oncology (2024) 102 (12): 1084–1096.
https://doi.org/10.1159/000540542
Acknowledgement to Reviewers
Acknowledgement to Reviewers
Subject Area:
Oncology
Oncology (2024) 102 (12): 1097–1098.
https://doi.org/10.1159/000542092
Contents Vol. 102, 2024
Subject Area:
Oncology
Oncology (2024) 102 (12): I.
https://doi.org/10.1159/000542533
